Peer Review History

Original SubmissionMarch 16, 2020
Decision Letter - Tao Huang, Editor

PONE-D-20-07569

Impact of processing method on donated human breast milk microRNA content

PLOS ONE

Dear Dr. Smyczynska,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jul 03 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Tao Huang

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as: a) the recruitment date range (month and year), b) a description of any inclusion/exclusion criteria that were applied to participant recruitment, c) a table of relevant demographic details, d) a statement as to whether your sample can be considered representative of a larger population, e) a description of how participants were recruited, and f) descriptions of where participants were recruited and where the research took place.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: First I want to appreciate the investigators for the great work done. This study is an incredible assessment for miRNAs and the functioning in infants. This study highlights great advances in breast milk donation practices and much required knowledge in this field.

My review is based on the questions above;

1. The manuscript is generally sound but there is a great need for increment in sample size, the analysis proved that need but ultimately the knowledge has been well explained.

2. The interplay of analysis between function and composition based on the processing method was well elaborated. This was one of my strongest points.

3. The data was made available. More analysis on function in relation to miRNAs especially on the processes can be generated if possible.

4. Standard English was used. I believe they however meant "revealed" and not revelled in the discussion concerning HPP on line 328. This can be clarified please.

I would love to encourage the authors to explore more information on the composition of breast milk in relation to other products after the preservation method used.

Thank you

Reviewer #2: This manuscript by Smyczynska et al describes the differences of two different processing methods on donated human breast milk on microRNA level. This subject is of high interest and the analysis of influence of HoP and HPP on micro RNAs is unique although many publications already claimed that HPP preserves proteins and other nutrients better than HoP.

The paper is well structured and has a good readability although I would recommend a native English reviewer. The main weakness in this study I see in the sample size. Only three samples were analyzed and one sample (B) was additionally excluded. At least I want to see a critical discussion about this fact. Nevertheless, they supported the theory for using HPP processing in a well structured and clear way and supported it with nice and clear figures.

Other comments:

L28: et al. instead of at al.

L43: Recommendations From, no capital letters

L117: six instead of 6

L167 and L328: revealed instead of reveled

Reviewer #3: The authors of the manuscript compared the total and exosome-bound content of small noncoding RNAs (miRNAs) in human milk depending on two preservation methods (HoP and HPP). Authors showed that HPP is less detrimental to human milk miRNAs than HoP and thus has a potential as a processing procedures for human milk banks.

In general, the comparative analysis is very essential because could have an impact on the miRNA level in infants.

However, I have only small concerns about the study design, and believe that some additional experiments or data are required to support the conclusions.

Unfortunately, I was not able to find the access the sequences of the study. Please submit the .fastq data from miRNA to https://www.ebi.ac.uk/ena.

Authors used milk samples, obtained on the 50th day of lactation. Why not the 90th day or colostrum samples? Authors should explain the selection.

Do you have any information about the bacterial composition of the investigated milk (unprocessed vs HPP samples)? If yes, please provide or discuss. Latest studies as reviewed by Simpson et al, 2015 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682386/ have highlighted that the expression of miRNAs is profoundly impacted by a variety of bacterial pathogens and that likewise miRNAs impose strong pressure to the invading microorganisms.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr Okurut Emmanuel

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Editors and Reviewers,

Thank you for consideration of our manuscript and your time and effort put into making it more accessible and informative. We introduced the suggested corrections wherever it was possible and discuss our rationale for taking specific course of action. Please find responses to particular comments in the list below. As several points of the reviews are repeated we have answered them in jointly, marking with respective numbers the reviews which they address

Editorial comments:

In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as: a) the recruitment date range (month and year), b) a description of any inclusion/exclusion criteria that were applied to participant recruitment, c) a table of relevant demographic details, d) a statement as to whether your sample can be considered representative of a larger population, e) a description of how participants were recruited, and f) descriptions of where participants were recruited and where the research took place.

Reviewer #1: First I want to appreciate the investigators for the great work done. This study is an incredible assessment for miRNAs and the functioning in infants. This study highlights great advances in breast milk donation practices and much required knowledge in this field.

My review is based on the questions above;

1. The manuscript is generally sound but there is a great need for increment in sample size, the analysis proved that need but ultimately the knowledge has been well explained.

2. The interplay of analysis between function and composition based on the processing method was well elaborated. This was one of my strongest points.

3. The data was made available. More analysis on function in relation to miRNAs especially on the processes

can be generated if possible.

4. Standard English was used. I believe they however meant "revealed" and not revelled in the discussion concerning HPP on line 328. This can be clarified please.

Reviewer #2: This manuscript by Smyczynska et al describes the differences of two different processing methods on donated human breast milk on microRNA level. This subject is of high interest and the analysis of influence of HoP and HPP on micro RNAs is unique although many publications already claimed that HPP preserves proteins and other nutrients better than HoP.

The paper is well structured and has a good readability although I would recommend a native English reviewer. The main weakness in this study I see in the sample size. Only three samples were analyzed and one sample (B) was additionally excluded. At least I want to see a critical discussion about this fact. Nevertheless, they supported the theory for using HPP processing in a well structured and clear way and supported it with nice and clear figures.

Other comments:

L28: et al. instead of at al.

L43: Recommendations From, no capital letters

L117: six instead of 6

L167 and L328: revealed instead of reveled

Reviewer #3: The authors of the manuscript compared the total and exosome-bound content of small noncoding RNAs (miRNAs) in human milk depending on two preservation methods (HoP and HPP). Authors showed that HPP is less detrimental to human milk miRNAs than HoP and thus has a potential as a processing procedures for human milk banks.

In general, the comparative analysis is very essential because could have an impact on the miRNA level in infants.

However, I have only small concerns about the study design, and believe that some additional experiments or data are required to support the conclusions.

Unfortunately, I was not able to find the access the sequences of the study. Please submit the .fastq data from miRNA to https://www.ebi.ac.uk/ena.

Authors used milk samples, obtained on the 50th day of lactation. Why not the 90th day or colostrum samples? Authors should explain the selection.

Do you have any information about the bacterial composition of the investigated milk (unprocessed vs HPP samples)? If yes, please provide or discuss. Latest studies as reviewed by Simpson et al, 2015 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682386/ have highlighted that the expression of miRNAs is profoundly impacted by a variety of bacterial pathogens and that likewise miRNAs impose strong pressure to the invading microorganisms.

Responses:

RE&R1: In response to the Editor’s and Reviwer’s requests, available data about milk donors were included in the manuscript. All 3 recruited women were on the regular basis the milk donors to the Regional Human Milk Bank in Holy Family Hospital in Warsaw, Poland. They were healthy and fulfilled the requirements of becoming milk donors (no addictions and excluded severe chronic diseases).

R1&R2: The low number of samples, pointed by Reviewer #1 and Reviewer #2, was elaborated in depth to the discussion as the limitation of the study. Our main explanation of using only 3 milk samples is the number of analysed conditions for each of them (3 processing methods and 2 types of material – whole milk and exosomes, yielding 6 assays per sample in total). Having only 3 samples, it is difficult to determine with certainty if they are representative for whole population. However, we do not expect our samples to significantly differ from typical, normal milk composition, since the volunteers’ health was sufficiently good to allow them to become milk donors.

R1&R3: Milk samples were obtained at 50th day of lactation, because we were interested in investigating mature milk that changes less over time then early milk (colostrum or transitional milk). According to the literature at the 50th day of lactation milk is already fully mature and we should not expect much different results if it had been donated later. A similar comment was added to the manuscript as per Reviewer’s #3 request.

R1: The literature on the effect of food processing on miRNA content was added to relevant sections as suggested by Reviewer #1. Such studies are however very limited in number and usually concern thermal processing methods, while the High Pressure Processing of dietary products is much less studied. Diary products were analysed most often and results vary, but the general consensus seems to be that elevated temperature leads to partial or complete degeneration of miRNA in food.

R3 Bacterial composition of milk treated with either pasteurization method was not analysed in our study, since previous studies showed that both Holder Pasteurization and HPP effectively inactivate microorganisms that may be present in food. We know that the volunteers had not presented any symptoms of infections, including mammary gland infections when milk was obtained as per requirements posed to milk donors in our milk bank. We agree with Reviewer #3 that analysis of effect of bacteria on miRNA profile of breast milk would be interesting, but it would require substantially more samples and a completely different study design most likely focusing on a large cohort of breastfeeding mothers to evaluate the population variability of bacteria colonizing the breast and their potential to spread onto expressed milk. While undoubtedly interesting, such a study would be highly divergent from what we could do with the current design.

R1&R3 The sequences from our study in FASTQ files had already been deposited in NCBI Sequence Read Archive (SRA) under the accession number SRP238092 and this data is linked to our Gene Expression Omnibus (GEO) entry identified by accession number GSE142282. We support open science and sharing research data, but we believe that it is enough to use one repository where data is freely available to research community.

R1&R2 Typesetting errors, indicated by all reviewers, were corrected. The only exception is line 43 where we left “Recommendations From” with “From” starting with capital letter, since it is used in this form in the document that is cited there.

Should you need any more information feel free to contact me at your convenience at wojciech_fendler@dfci.harvard.edu.

Wojciech Fendler

Attachments
Attachment
Submitted filename: Response_to_Reviews_Human_milk_miRNA_PLOS_ONE.pdf
Decision Letter - Tao Huang, Editor

Impact of processing method on donated human breast milk microRNA content

PONE-D-20-07569R1

Dear Dr. Smyczynska,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tao Huang

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The authors addressed my comments and changed inaccuracies carefully. The argument on the low sample-size was highlighted and spelling mistakes were corrected. Also the comments of the other authors were addressed. Great work was done on an important topic.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Christian Robben

Reviewer #3: No

Formally Accepted
Acceptance Letter - Tao Huang, Editor

PONE-D-20-07569R1

Impact of processing method on donated human breast milk microRNA content

Dear Dr. Smyczynska:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tao Huang

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .